Medical Application of Hyaluronan

Chemistry and Biology of Hyaluronan

Volumn , Issue , 2004, Pages 457-473

  Asari, Arira ^a  

^a SEIKAGAKU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SYSTEMS; BIOMEDICAL EQUIPMENT; CELLS; CYTOLOGY; MEDICAL APPLICATIONS; MOLECULAR WEIGHT; SIGNAL TRANSDUCTION;

BINDING PROTEINS; BIOLOGICAL FUNCTIONS; HIGH MOLECULAR WEIGHT; HYALURONAN; LOW MOLECULAR WEIGHT; MEDICAL DEVICES; NOVEL FUNCTIONS; PHYSICOCHEMICAL PROPERTY;

HYALURONIC ACID;

EID: 84940857277     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008044382-9/50052-2     Document Type: Chapter

References (73)

1. West DC, Shaw DM Tumour hyaluronan in relation to angiogenesis and metastasis. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives 1998, 227-233. Portland Press, London. T.C. Laurent (Ed.).
2. Noble PW, Lake FR, Henson PM, Riches DW Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factoralpha-dependent mechanism in murine macrophages. J Clin Investig 1993, 91:2368-2377.
3. Xu H, Ito T, Tawada A, Maeda H, Yamanokuchi H, Isahara K, Yoshida K, Uchiyama Y, Asari A Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J Biol Chem 2002, 277:17308-17314.
4. Ghatak S, Misra S, Toole BP Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002, 277:38013-38020.
5. Neumann A, Schinzel R, Palm D, Riederer P, Munch G High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 1999, 453:283-287.
6. Balazs EA Sodium hyaluronate and viscosurgery. Healon (Sodium Hyaluronate). A Guide to Its Use in Ophthalmic Surgery 1983, 5-28. Wiley, New York. D. Miller, R. Stegmann (Eds.).
7. Liesegang TJ Viscoelastic substances in ophthalmology. Surv Ophthalmol 1990, 34:268-293.
8. Yamamoto H, Kawata H, Sunada K, Satoh K, Kaneko Y, Ido K, Sugano K Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate. Gastrointest Endosc 2002, 56:507-512.
9. Yamamoto H, Sekine Y, Higashizawa T, Kihira K, Kaneko Y, Hosoya Y, Ido K, Saito K, Sugano K Successful en bloc resection of a large superficial gastric cancer by using sodium hyaluronate and electrocautery incision forceps. Gastrointest Endosc 2001, 54:629-632.
10. Yu Q, Toole BP, Stamenkovic I Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997, 186:1985-1996.
11. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 1998, 77:396-401.
12. Turley EA, Noble PW, Bourguignon LY Signaling properties of hyaluronan receptors. J Biol Chem 2002, 277:4589-4592.
13. Misra S, Ghatak S, Zoltan-Jones A, Toole BP Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003, 278:25285-25288.
14. Lesley J, Hyman R CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 1992, 22:2719-2723.
15. Levesque MC, Haynes BF Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol 1997, 159:6184-6194.
16. Weiss JM, Renkl AC, Ahrens T, Moll J, Mai BH, Denfeld RW, Schopf E, Ponta H, Herrlich P, Simon JC Activation-dependent modulation of hyaluronate-receptor expression and of hyaluronate-avidity by human monocytes. J Investig Dermatol 1998, 111:227-232.
17. Yanagisawa N, Mikami T, Mitomi H, Saegusa M, Koike M, Okayasu I CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Cancer 2001, 91:408-416.
18. Katoh S, Taniguchi H, Matsubara Y, Matsumoto N, Fukushima K, Kadota J, Matsukura S, Kohno S Overexpression of CD44 on alveolar eosinophils with high concentrations of soluble CD44 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia. Allergy 1999, 54:1286-1292.
19. Luo Y, Bernshaw NJ, Lu ZR, Kopecek J, Prestwich GD Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res 2002, 19:396-402.
20. Sakurai K, Miyazaki K, Kodera Y, Nishimura H, Shingu M, Inada Y Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate. Glycoconj J 1997, 14:723-728.
21. Asayama S, Nogawa M, Takei Y, Akaike T, Maruyama A Synthesis of novel polyampholyte comb-type copolymers consisting of a poly(l-lysine) backbone and hyaluronic acid side chains for a DNA carrier. Bioconjug Chem 1998, 9:476-481.
22. Balazs EA, Denlinger JL Clinical uses of hyaluronan. Ciba Found Symp 1989, 143:265-275.
23. Fukuda K, Dan H, Takayama M, Kumano F, Saitoh M, Tanaka S Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J Pharmacol Exp Ther 1996, 277:1672-1675.
24. Sakamoto T, Mizuno S, Maki T, Suzuki T, Yamaguchi T, Iwata H Studies on the affinity of hyaluronic acid to the surface of articular cartilage and the suppression of proteoglycan release from matrix. Orthop Res Sci 1984, 11:264.
25. Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiyama Y Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol 1998, 61:125-135.
26. Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, Tokuyasu K Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 1993, 52:817-822.
27. Iwata H Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clin Orthop 1993, 289:285-291.
28. Kikuchi T, Yamada H, Shinmei M Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cartilage 1996, 4:99-110.
29. Ghosh P, Read R, Armstrong S, Wilson D, Marshall R, McNair P The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. I. Gait analysis and radiological and morphological studies. Semin Arthritis Rheum 1993, 122(6 Suppl 1):18-30.
30. Huebner JL, Hanes MA, Beekman B, TeKoppele JM, Kraus VB A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage 2002, 10:758-767.
31. Yanaki T, Yamaguchi T Temporary network formation of hyaluronate under a physiological condition. 1. Molecular-weight dependence. Biopolymers 1990, 30:415-425.
32. Yasui T, Akatsuka M, Tobetto K, Hayaishi M, Ando T The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells. Agents Actions 1992, 37:155-156.
33. Goldberg RL, Toole BP Hyaluronate inhibition of cell proliferation. Arthritis Rheum 1987, 30:769-778.
34. Shimizu C, Kubo T, Hirasawa Y, Coutts RD, Amiel D Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis. J Rheumatol 1998, 25:1813-1819.
35. Yamashita I, Atsuta Y, Shimazaki S, Miyatsu M Effects of prostaglandin E2 and sodium hyaluronate on bradykinin induced knee joint pain in rat. Nippon Seikeigeka Gakkai Zasshi-Jpn Orthop Assoc 1995, 69:735-743.
36. Asari A, Mizuno S, Tanaka I, Sunose A, Kuriyama S, Miyazaki K, Namiki O Suppression of hyaluronan and prostaglandin E2 production in traumatic arthritic synovial cells by NaHA. Connect Tissue 1997, 29:1-5.
37. Homandberg GA, Hui F, Wen C, Kuettner KE, Williams JM Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthritis Cartilage 1997, 5:309-319.
38. Takeshita S, Mizuno S, Kukuchi T, Yamada H, Namiki O, Horie K The in vitro effect of hyaluronic acid on IL-1 production in cultured rheumatoid synovial cells. Biomed Res 1997, 18:187-194.
39. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999, 7:182-190.
40. Asari A, Miyauchi S, Sekiguchi T, Machida A, Kuriyama S, Miyazaki K, Namiki O Hyaluronan, cartilage destruction and hydrarthrosis in traumatic arthritis. Osteoarthritis Cartilage 1994, 2:79-89.
41. Toole BP, Jackson G, Gross J Hyaluronate morphogenesis: inhibition of chondrogenesis in vitro. Proc Natl Acad Sci USA 1972, 69:1384-1386.
42. Toole BP Hyaluronan-cell interactions in morphogenesis. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives 1998, 155-160. Portland Press, London. T.C. Laurent (Ed.).
43. Scott JE The chemical morphology of the vitreous. Eye 1992, 6:553-555.
44. Grigolo B, Lisignoli G, Piacentini A, Fiorini M, Roseti L, Major EO, Duca M, Pavesio A, Facchini A Evidence for re-differentiation of human chondrocytes seeded on an HA derivative scaffold innovative rheumatology: gene and cell therapies of arthritis and related autoimmune disorders. Arthritis Res 2001, 3:7.
45. Hollander D, Stein M, Bernd A, Windolf J, Pannike A Autologous keratinocytes cultured on benzylester hyaluronic acid membranes in the treatment of chronic full-thickness ulcers. J Wound Care 1999, 8:351-355.
46. Galassi G, Brun P, Radice M, Cortivo R, Zanon GF, Genovese P, Abatangelo G In vitro reconstructed dermis implanted in human wounds: degradation studies of the HA-based supporting scaffold. Biomaterials 2000, 21:2183-2191.
47. Hall CL, Wang C, Lange LA, Turley EA Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 1994, 126:575-588.
48. Ho N, Koziol JA, Parsons CL Epidemiology of interstitial cystitis. Interstitial Cystitis 1997, 9-16. Lipincott-Raven, Philadelphia. G.R. Sant (Ed.).
49. Parsons CL The therapeutic role of sulfated polysaccharides in urinary bladder. Urol Clin N Am 1994, 21:93-100.
50. Sant GR, LaRock DR Standard intravesical therapies for interstitial cystitis. Urol Clin N Am 1994, 21:73-83.
51. Parsons CL, Housley T, Schmidt JD, Lebow D Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994, 73:504-507.
52. Edwards L, Bucknall TE, Makin C Interstitial cystitis: possible cause and clinical study of sodium cromoglycate. Br J Urol 1986, 58:95-96.
53. Khanna OP, Loose JH Interstitial cystitis treated with intravesical doxorubicin. Urology 1990, 36(Suppl):139-142.
54. Zeidman EJ, Helfrick B, Pollard C, Thompson IM Bacillus Calmette-Guerin immunotherapy for refractory interstitial cystitis. Urology 1994, 43:121-124.
55. Parsons CL, Lilly JD, Stein P Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991, 145:732-735.
56. Ruggieri MR, Chelsky MJ, Rosen SI, Schikley TJ, Hanno PM Current findings and future research avenues in the study of interstitial cystitis. Urol Clin N Am 1994, 21:163-176.
57. Morales A, Emerson L, Nickel JC, Lundie M Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 1996, 156:45-48.
58. Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 1997, 59:26-29.
59. Takahashi K, Takeuchi J, Takahashi T, Miyauchi S, Horie K, Uchiyama Y Effects of sodium hyaluronate on epithelial healing of the vesical mucosa and vesical fibrosis in rabbits with acetic acid induced cystitis. J Urol 2001, 166:710-713.
60. Erickson DR, Sheykhnazari M, Ordille S, Bhavanendan VP Increased urinary hyaluronic acid and interstitial cystitis. J Urol 1998, 160:1282-1284.
61. Asari A, Morita M, Sekiguchi T, Okamura K, Horie K, Miyauchi S Hyaluronan, CD44 and fibronectin in rabbit corneal epithelial wound healing. Jpn J Ophthalmol 1996, 40:18-25.
62. Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 2002, 167:380-384.
63. Miyazaki T, Miyauchi S, Nakamura T, Takeshita S, Horie K The effect of sodium hyaluronate on the growth of rabbit corneal epithelial cells in vitro. J Ocul Pharmacol 1996, 12:409-415.
64. Miyauchi S, Sugiyama T, Machida A, Sekiguchi T, Miyazaki K, Tokuyasu K, Nakazawa K The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. I. An in vitro study. J Ocul Pharmacol 1990, 6:91-99.
65. Ghellai AM, Stucchi AF, Lynch DJ, Skinner KC, Colt MJ, Becker JM Role of a hyaluronate-based membrane in the prevention of peritonitis-induced adhesions. J Gastrointest Surg 2000, 4:310-315.
66. Osada H, Takahashi K, Fujii TK, Tsunoda I, Satoh K The effect of cross-linked hyaluronate hydrogel on the reduction of post-surgical adhesion reformation in rabbits. J Int Med Res 1999, 27:233-241.
67. Holtz G Prevention of postoperative adhesions. J Reprod Med 1980, 24:141-146.
68. Weigel PH, Frost SJ, LeBoeuf RD, McGary CT The specific interaction between fibrin (ogen) and HA: possible consequences in haemostasis, inflammation and wound healing. Ciba Found Symp 1989, 143:248-261.
69. Nagler A, Genina O, Lavelin I, Ohana M, Pines M Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model. Am J Obstet Gynecol 1999, 180:558-563.
70. Coleman PJ Evidence for a role of hyaluronan in the spacing of fibrils within collagen bundles in rabbit synovium. Biochim Biophys Acta 2002, 1571:173-182.
71. Meenakshi J, Anupama, Goswami SK, Datta K Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1 qR) in normal fibroblast cells perturbs its growth characteristics and induces apoptosis. Biochem Biophys Res Commun 2003, 300:686-693.
72. Huang L, Grammatikakis N, Yoneda M, Banerjee SD, Toole BP Molecular characterization of a novel intracellular hyaluronan-binding protein. J Biol Chem 2000, 275:29829-29839.
73. Vostrov AA, Quitschke WW Plasma hyaluronan-binding protein is a serine protease. J Biol Chem 2000, 275:22978-22985.